Sanofi S.A. News
Fabry Disease Patients Get Sicker as Drugs Go Overseas
Patients Report Strokes and Kidney Failure in Suit Against Pharmaceutical Co. Genzyme
Sleepwalking May Have Led to N.J. Woman's Drowning
It's not unusual for people to walk or talk in their sleep. But on Sunday morning, a New Jersey woman may have sleepwalked to her death. The body of Charlene Ferrero, 55, was found Monday in Newton Lake near Oaklyn, N.J. Calls to the Oaklyn Police Department were not immediately returned, but WPVI
10 Top-Selling Drugs Coming Off Patent
Ten of the world's top-selling prescription drugs are about to get cheaper. Over the next 17 months, the patents on brand-name medications like the cholesterol-lowering drug Lipitor and the blood thinner Plavix will expire, opening the door for generic versions that could cost up to 80 percent
FDA Panel Supports New Diet Pill After Rejecting Two Others
Contrave is the only diet pill to survive FDA scrutiny in 2010, but no decision expected until January.
Dengue Fever 101
Dengue (pronounced DEN-ghee) fever is a tropical disease spread by mosquitoes . It is caused by any one of four closely related dengue viruses -- DENV 1, DENV 2, DENV 3 or DENV 4 -- carried most often by the Aedes aegypti mosquito, and less frequently, by Aedes albopictus. The most common
After the Headlines, What Is the Real Avandia Story?
Controversy continues to surround Avandia -- a drug used to treat type 2 diabetes that has been linked to heart failure. As a result, a question that emerged here at the American Diabetes Association meeting was whether the class of drug, called "thiazolidinediones," which includes Avandia and its
New Anti-Clotting Drug Outperforms Plavix
WEDNESDAY, Jan. 13 (HealthDay News) -- A new clot-busting drug, Brilinta, may soon take the place of Plavix in treating patients with acute coronary syndrome, which includes angina and heart attack. In a new trial, the upstart drug, ticagrelor (Brilinta) reduced the risk of second heart attacks and
Manufacturer Recalls 800,000 Doses of H1N1 Vaccine; Flu Experts Not Worried
No big deal. That's what infectious disease experts are saying about drugmaker Sanofi Pasteur's recall of about 800,000 pediatric doses of its vaccine against pandemic H1N1 influenza because of low potency . The recall was announced by the U.S. Centers for Disease Control and Prevention on Tuesday.
Health Highlights: Dec. 2, 2009
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay : NFL Issues Tougher Rules on Handling of Head Injuries NFL Commissioner Roger Goodell on Wednesday sent a memo to the league's 32 professional football teams outlining the toughest rules yet for